Health Service Medical Supplies (Costs) Act 2017
Jurisdiction | UK Non-devolved |
Citation | 2017 c. 23 |
Year | 2017 |
- “(8A) Regulations may impose requirements in relation to remuneration in respect of special medicinal products.
- (8B) Such regulations may, for example, require determining authorities to ensure—
- (a) that remuneration is to be calculated by reference to the outcome of prescribed procedures, or
- (b) that determinations do not provide for or permit remuneration to be paid in prescribed circumstances.
- “health service body” has the meaning given by section 9(4) ;
- “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 (S.I. 2012/1916) .
- “(8A) Regulations may impose requirements in relation to remuneration in respect of special medicinal products.
- (8B) Such regulations may, for example, require determining authorities to ensure—
- (a) that remuneration is to be calculated by reference to the outcome of prescribed procedures, or
- (b) that determinations do not provide for or permit remuneration to be paid in prescribed circumstances.
- “health service body” has the meaning given by section 7(4) ;
- “special medicinal product” means a product which is a special medicinal product for the purposes of regulation 167 of the Human Medicines Regulations 2012 (S.I. 2012/1916) .
- (c) providing for any manufacturer or supplier to whom the scheme relates to pay to the Secretary of State an amount calculated by reference to sales or estimated sales of any health service medicines (whether on the basis of net prices, average selling prices or otherwise) .
- “(9) The Secretary of State may provide for any amount payable in accordance with a voluntary scheme by any manufacturer or supplier to whom the scheme applies to be paid to the Secretary of State within a specified period.
- (10) Neither of the following affects any liability of a manufacturer or supplier to pay amounts to the Secretary of State arising during a period when a health service medicine was covered by a voluntary scheme treated as applying to the person or the taking of any action in relation to any such liability—
- (a) the withdrawal of consent by the person to the scheme being treated as applying to the person;
- (b) the giving of notice to the person under subsection (4) .
- (c) providing for any manufacturer or supplier of any health service medicines to pay to the Secretary of State an amount calculated by reference to sales or estimated sales of those medicines (whether on the basis of net prices, average selling prices or otherwise) .
- “(1A) Consultation about the proposed exercise of a power under subsection (1) must include consultation about the following—
- (a) the economic consequences for the life sciences industry in the United Kingdom;
- (b) the consequences for the economy of the United Kingdom;
- (c) the consequences for patients to whom any health service medicines are to be supplied and for other health service patients.
- “(5A) The scheme may provide for any amount payable in accordance with the scheme by any manufacturer or supplier to whom the scheme applies to be paid to the Secretary of State within a specified period.
- “(7) If at any time a health service medicine is covered by a voluntary scheme applying to its manufacturer or supplier, the powers conferred by this section may not be exercised at that time in relation to that manufacturer or supplier as regards that medicine.
- “(8) Subsection (7) does not affect any liability of a person to pay amounts to the Secretary of State arising during a period when a health service medicine was covered by a statutory scheme applying to the person or the taking of any action in relation to any such liability.
To continue reading
Request your trial